Li How Chen

Title: Innovations of Li How Chen

Introduction

Li How Chen is an accomplished inventor based in Acton, MA (US). She has made significant contributions to the field of biotechnology, particularly in the development of modified nucleic acid sequences. With a total of three patents to her name, her work focuses on enhancing mRNA levels and protein expression in various cell systems.

Latest Patents

One of her notable patents is titled "Modified nucleic acid sequences and methods for increasing mRNA levels and protein expression in cell systems." This invention provides modified recombinant nucleic acid sequences, preferably DNA, and methods aimed at increasing mRNA levels and protein expression of proteins that are challenging to express in cell culture systems, mammalian cell culture systems, or transgenic animals. The invention particularly targets proteins derived from heterologous cells, especially those from lower organisms such as parasites, bacteria, and viruses, which often have DNA coding sequences with high overall AT content or AT-rich regions.

Another significant patent is "Merozoite surface protein 1 lacking glycosylation sites." This invention also provides modified recombinant nucleic acid sequences and methods for increasing the mRNA levels and protein expression of malarial surface protein MSP-1, which is known to be difficult to express in various cell systems. The techniques focus on MSP-1 proteins expressed from DNA coding sequences that have reduced overall AT content or AT-rich regions.

Career Highlights

Li How Chen has worked with prominent companies in the biotechnology sector, including GTC Biotherapeutics, Inc. and Genzyme Transgenics Corporation. Her experience in these organizations has contributed to her expertise in the field and her ability to innovate effectively.

Collaborations

Li has collaborated with various professionals throughout her career, including her coworker Harry M Meade, who has also contributed to advancements in biotechnology.

Conclusion

Li How Chen's innovative work in the field of biotechnology, particularly in the development of modified nucleic acid sequences, showcases her dedication to enhancing protein expression and mRNA levels. Her contributions are significant in addressing challenges in cell culture systems and advancing scientific research.